ArticleCancer discovery2016

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.

Shannon Elf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.